info@businessbreakthrough.net

Apr 17, 2024

Grand News Network / November 8, 2023

Class Action Lawsuit Filed Against SCYNEXIS, Inc. (SCYX) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ:SCYX). The lawsuit alleges SCYNEXIS made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including: (1) that the equipment used to manufacture ibrexafungerp was also used to manufacture a non-antibacterial beta-lactam drug substance, presenting a risk of cross-contamination; (2) that the Company did not have effective internal controls and procedures, as well as adequate internal oversight policies to ensure that its vendor complied ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner